| 738 |
Uranium, soluble salts
|
-
Uranium, soluble salts, CAS-RN: NOCAS, DTXSID7024374
|
447: Kidney failure induced by inhibition of mitochondrial electron transfer chain through apoptosis, inflammation and oxidative stress pathways
|
| 369 |
Polyoxin B
|
-
Polyoxin B, CAS-RN: 19396-06-6, DTXSID3058329
|
360: Chitin synthase 1 inhibition leading to mortality
|
| 594 |
Captafol
|
-
Captafol, CAS-RN: 2425-06-1, DTXSID4020242
|
360: Chitin synthase 1 inhibition leading to mortality
|
| 595 |
Captan
|
-
Captan, CAS-RN: 133-06-2, DTXSID9020243
|
360: Chitin synthase 1 inhibition leading to mortality
|
| 596 |
Folpet
|
-
Folpet, CAS-RN: 133-07-3, DTXSID0021385
|
360: Chitin synthase 1 inhibition leading to mortality
|
| 368 |
Nikkomycins
|
-
Nikkomycins, CAS-RN: 59456-70-1, DTXSID5058436
|
360: Chitin synthase 1 inhibition leading to mortality
|
| 621 |
DX600
|
|
319: Binding to ACE2 leading to lung fibrosis
|
| 739 |
welding fumes
|
|
451: Interaction with lung resident cell membrane components leads to lung cancer
|
| 740 |
Carbon black
|
-
Carbon black, CAS-RN: 1333-86-4, DTXSID7051216
|
451: Interaction with lung resident cell membrane components leads to lung cancer
|
| 598 |
Exemestane
|
-
Exemestane, CAS-RN: 107868-30-4, DTXSID5023037
|
346: Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation
|
| 741 |
DCA
|
|
335: AOP for urothelial carcinogenesis due to chemical cytotoxicity by mitochondrial impairment
|
| 742 |
DCPMU
|
|
335: AOP for urothelial carcinogenesis due to chemical cytotoxicity by mitochondrial impairment
|
| 743 |
Niclosamide ethanolamine
|
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 744 |
Oxyclozanide
|
-
Oxyclozanide, CAS-RN: 2277-92-1, DTXSID50177312
|
263: Uncoupling of oxidative phosphorylation leading to growth inhibition via decreased cell proliferation
|
| 599 |
Stressor:292 Clotrimazole
|
|
346: Aromatase inhibition leads to male-biased sex ratio via impacts on gonad differentiation
|
| 334 |
low molecular weight proteins
|
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 331 |
Polymyxin B
|
-
Polymyxin B, CAS-RN: 1404-26-8, DTXSID1048467
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 332 |
Colistin
|
-
Colistin, CAS-RN: 1066-17-7, DTXSID1040663
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 333 |
Albumin
|
-
Albumin, CAS-RN: 308060-74-4, DTXSID1040409
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 616 |
TAK-242
|
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 612 |
curcumin
|
-
Curcumin, CAS-RN: 458-37-7, DTXSID8031077
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 611 |
Pralnacasan (VX-740, HMR3480)
|
|
277: Impaired IL-1R1 signaling leading to Impaired T-Cell Dependent Antibody Response
|
| 340 |
Methoxyacetic acid
|
-
Methoxyacetic acid, CAS-RN: 625-45-6, DTXSID1031591
|
212: Histone deacetylase inhibition leading to testicular atrophy
|
| 330 |
Vancomycin
|
-
Vancomycin, CAS-RN: 1404-90-6, DTXSID0042664
|
257: Receptor mediated endocytosis and lysosomal overload leading to kidney toxicity
|
| 336 |
Acrylamide
|
-
Acrylamide, CAS-RN: 79-06-1, DTXSID5020027
|
17: Binding of electrophilic chemicals to SH(thiol)-group of proteins and /or to seleno-proteins involved in protection against oxidative stress during brain development leads to impairment of learning and memory
|